---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-26-005349"
form_type: "8-K"
ticker: "UG"
cik: "0000101295"
company_name: "UNITED GUARDIAN INC"
filed_at: "2026-08-07T14:30:21+00:00"
generated_at: "2026-08-07T14:31:07.227657+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# United-Guardian Q2 net income up 16% to $728,579; sales up 10% to $3.1M

## Summary
- Q2 net sales $3,108,267, up 10% from $2,838,225; net income $728,579 ($0.16/diluted), up 16% from $626,826 ($0.14).
- Six-month net sales $5,980,489, up 12% from $5,319,352; net income $1,547,481 ($0.34), up 30% from $1,187,721 ($0.26).
- Cosmetic ingredient sales up 44% in Q2 and 34% in H1, driven by resumed purchasing from largest distributor Ashland Specialty Ingredients (ASI).
- Pharmaceutical sales up 1% in Q2 and 11% in H1, led by Renacidin; company focused on growth plan for rest of 2026.

## SEC filing metadata
- accession: 0001171843-26-005349
- form_type: 8-K
- ticker: UG
- cik: 0000101295
- company_name: UNITED GUARDIAN INC
- filed_at: 2026-08-07T14:30:21+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/101295/000117184326005349/0001171843-26-005349-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/101295/000117184326005349/f8k_080726.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-26-005349
- JSON: https://secwatch.observer/filing/0001171843-26-005349.json
- Plain text: https://secwatch.observer/filing/0001171843-26-005349.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.